SUBSEQUENT EVENT (Tables)

6 Months Ended

Mar. 31, 2021

SUBSEQUENT EVENT

Schedule of Term Loans

Loan Name	Principal		Annual		Monthly
	Amount as of		Interest		Payment
	date of Credit		Rate		Amount
	Agreement				(000)		Maturity Date	Use of Proceeds
Term Loan 1	$	3.980 million	5.20	%	$	36	March 28, 2025	Funded expansion of building on real property in Mount Vernon, IN
Term Loan 2	$	3.571 million	5.06	%	$	78	July 2, 2023	Funded a portion of the cash consideration for the Seventh Wave Laboratories acquisition
Term Loan 3	$	1.076 million	5.20	%	$	32	March 28, 2025	Funded equipment needs associated with expansion of real property in Mount Vernon, IN
Term Loan 4	$	1.001 million	4.63	%	$	20	November 1, 2025	Funded the cash consideration for the Smithers Avanza acquisition
Term Loan 5	$	810 thousand	4.00	%	$	17	June 30, 2025	Funded certain capital expenditures
Term Loan 6	$	2.865 million	4.25	%	$	56	December 31, 2025	Funded certain capital expenditures
Term Loan 7	$	1.263 million	4.00	%	$	28	June 1, 2025	Financed aspects of the Pre-Clinical Research Services and related real property acquisitions
Term Loan 8	$	1.853 million	4.00	%	$	12	December 1, 2024	Financed aspects of the Pre-Clinical Research Services and related real property acquisitions
Term Loan 9	$	10.000 million	3.85	%	$	184*	April 30, 2026	Funded a portion of the cash consideration of the Merger
Term Loan 10	$	5.000 million	3.85	%	$	92*	April 30, 2026	Funded a portion of the cash consideration of the HistoTox Labs Acquisition
Term Loan 11	$	3.622 million	3.99	%	$	33	June 23, 2022	Refinanced debt with The Huntington Bank for general business purposes